Literature DB >> 11059122

Hepatitis C: medical information update. Canadian Liver Foundation. National Hepatitis C Education Program.

.   

Abstract

Mesh:

Substances:

Year:  2000        PMID: 11059122      PMCID: PMC6979663     

Source DB:  PubMed          Journal:  Can J Public Health        ISSN: 0008-4263


× No keyword cloud information.
  12 in total

1.  An integrated protocol to manage health care workers exposed to bloodborne pathogens.

Authors: 
Journal:  Can Commun Dis Rep       Date:  1997-03

2.  Hepatitis C virus infection in a large cohort of homosexually active men: independent associations with HIV-1 infection and injecting drug use but not sexual behaviour.

Authors:  N J Bodsworth; P Cunningham; J Kaldor; B Donovan
Journal:  Genitourin Med       Date:  1996-04

Review 3.  Extrahepatic manifestations of hepatitis C and the association with alcoholic liver disease.

Authors:  R S Koff; J L Dienstag
Journal:  Semin Liver Dis       Date:  1995-02       Impact factor: 6.115

Review 4.  Management of viral hepatitis: clinical and public health perspectives--a consensus statement. CASL Hepatitis Consensus Group. Canadian Association for Study of the Liver.

Authors:  M Sherman
Journal:  Can J Gastroenterol       Date:  1997 Jul-Aug       Impact factor: 3.522

Review 5.  National Institutes of Health Consensus Development Conference Panel statement: management of hepatitis C.

Authors: 
Journal:  Hepatology       Date:  1997-09       Impact factor: 17.425

6.  Guidelines and recommendations on the prevention and control of hepatitis C. Laboratory Centre for Disease Control.

Authors: 
Journal:  Can Commun Dis Rep       Date:  1995-07

7.  Importance of heterosexual activity in the transmission of hepatitis B and non-A, non-B hepatitis.

Authors:  M J Alter; P J Coleman; W J Alexander; E Kramer; J K Miller; E Mandel; S C Hadler; H S Margolis
Journal:  JAMA       Date:  1989-09-01       Impact factor: 56.272

8.  Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients.

Authors:  G Fattovich; G Giustina; F Degos; F Tremolada; G Diodati; P Almasio; F Nevens; A Solinas; D Mura; J T Brouwer; H Thomas; C Njapoum; C Casarin; P Bonetti; P Fuschi; J Basho; A Tocco; A Bhalla; R Galassini; F Noventa; S W Schalm; G Realdi
Journal:  Gastroenterology       Date:  1997-02       Impact factor: 22.682

9.  Seroepidemiologic study of hepatitis C virus in sexually transmitted disease risk groups.

Authors:  A Stary; W Kopp; H Hofmann; C Heller-Vitouch; C Kunz
Journal:  Sex Transm Dis       Date:  1992 Sep-Oct       Impact factor: 2.830

10.  Risk factors for hepatitis C virus infection among health care personnel in a community hospital.

Authors:  L B Polish; M J Tong; R L Co; P J Coleman; M J Alter
Journal:  Am J Infect Control       Date:  1993-08       Impact factor: 2.918

View more
  1 in total

1.  Transitioning to highly effective therapies for the treatment of chronic hepatitis C virus infection: a policy statement and implementation guideline.

Authors:  Daniel John Smyth; Duncan Webster; Lisa Barrett; Mark MacMillan; Lisa McKnight; Frank Schweiger
Journal:  Can J Gastroenterol Hepatol       Date:  2014-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.